S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|U.S. FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), and for the Reduction in the Risk of Recurrent DVT and PE Following Initial Therapy|
|Secondary Analysis of AMPLIFY-EXT Examining Predictors of Hospitalization Presented at ESC Congress: Eliquis (apixaban) Significantly Reduced the Risk of All-Cause Hospitalization Versus Placebo in Patients with Venous Thromboembolism (VTE)|
|B2Q and FacilityConneX Partner to Deliver Advanced Continuous Commissioning and Energy Savings Solution (2014/10/15)|
|Advanced Drainage Systems' John Kurdziel Receives Prestigious ASTM Award|
|Parsley Energy Announces Midland Basin Acquisitions, Horizontal Well Result, Midstream Agreement, and Appointment of New Board Member (2014/8/25)|
|Parsley Energy to Participate at Upcoming Investor Conferences; Posts New Investor Presentation (2014/9/15)|
|Parsley Energy to Present at the Johnson Rice Energy Conference on October 1 (2014/9/24)|
|Parsley Energy Schedules Third Quarter 2014 Earnings Conference Call for November 12, 2014 (2014/10/14)|
|Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis® (apixaban) at the ESC Congress 2014|
|PFIZER REPORTS THIRD-QUARTER 2014 RESULTS|
Click above to view more mutual fund data and stats for pe - Pure Energy Minerals Ltd.